Eva Gil-Martins (Eva Martins)

ResearcherID Ciência ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Pharmaceutics

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Universidade do Porto Faculdade de Ciências

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade do Porto Faculdade de Ciências Feb 15o 2019 - May 31o 2019

Portugal

Bolsa de Investigação :: Química

Publications

Joana Torres, José Miguel Pereira, Rita Marques-Oliveira, Inês Costa, Eva Gil-Martins, Renata Silva, Fernando Remiao, Andreia Filipa Peixoto, José Manuel Sousa Lobo, Ana Catarina Silva
An In Vitro Evaluation of the Potential Neuroprotective Effects of Intranasal Lipid Nanoparticles Containing Astaxanthin Obtained from Different Sources: Comparative Studies. Pharmaceutics 15 (4) (2023)
Daniel Martins, Eva Gil-Martins, Fernando Cagide, Catarina da Fonseca, Sofia Benfeito, Carlos Fernandes, Daniel Chavarria, Fernando Remiao, Renata Silva, Fernanda Borges
Unraveling the In Vitro Toxicity Profile of Psychedelic 2C Phenethylamines and Their N -Benzylphenethylamine (NBOMe) Analogues. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Joana Torres, José Miguel Pereira, Rita Marques-Oliveira, Inês Costa, Eva Gil-Martins, Renata Silva, Fernando Remiao, Andreia Filipa Peixoto, José Manuel Sousa Lobo, Ana Catarina Silva
An In Vitro Evaluation of the Potential Neuroprotective Effects of Intranasal Lipid Nanoparticles Containing Astaxanthin Obtained from Different Sources: Comparative Studies. Pharmaceutics 15 (4) (2023)
Joana Torres, José Miguel Pereira, Rita Marques-Oliveira, Inês Costa, Eva Gil-Martins, Renata Silva, Fernando Remiao, Andreia Filipa Peixoto, José Manuel Sousa Lobo, Ana Catarina Silva
An In Vitro Evaluation of the Potential Neuroprotective Effects of Intranasal Lipid Nanoparticles Containing Astaxanthin Obtained from Different Sources: Comparative Studies. Pharmaceutics 15 (4) (2023)
Joana Torres, José Miguel Pereira, Rita Marques-Oliveira, Inês Costa, Eva Gil-Martins, Renata Silva, Fernando Remiao, Andreia Filipa Peixoto, José Manuel Sousa Lobo, Ana Catarina Silva
An In Vitro Evaluation of the Potential Neuroprotective Effects of Intranasal Lipid Nanoparticles Containing Astaxanthin Obtained from Different Sources: Comparative Studies. Pharmaceutics 15 (4) (2023)
Eva Gil-Martins, Vera Silva, Agostinho Lemos, Andreia Palmeira, Ploenthip Puthongking, Maria Emília Sousa, Carolina Rocha-Pereira, Carolina I Ghanem, Helena Carmo, Fernando Remiao, Renata Silva
Newly Synthesized Oxygenated Xanthones as Potential P-Glycoprotein Activators: In Vitro, Ex Vivo, and In Silico Studies. Molecules (Basel, Switzerland) 24 (4) (2019)
Miguel Pinto, Carlos Fernandes, Eva Gil-Martins, Renata Silva, Sofia Benfeito, Fernando Cagide, Ricardo Faria Mendes, Filipe A Almeida Paz, Jorge Garrido, Fernando Remiao, Fernanda Borges
Boosting Drug Discovery for Parkinson's: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles. Pharmaceutics 11 (7) (2019)

Eva Gil-Martins.css-eqlu8i{font-size:small;padding-left:4px;} (Eva Martins)

Publication Activity (10 Years)

Top Topics

Top Venues

Eva Gil-Martins (Eva Martins)